Literature DB >> 12444176

Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages.

Eleanor C Tsark1, Wei Wang, Yu-Chin Teng, Daniel Arkfeld, George R Dodge, Susan Kovats.   

Abstract

Rheumatoid arthritis is characterized by synovial joint infiltration of activated CD4(+) T cells and MHC class II(+) APC, and is linked to specific HLA-DR alleles. Candidate autoantigens in synovial fluid and cartilage include type II collagen (CII) and cartilage gp39 (HCgp39). Using preparations of native Ag and T cells derived from Ag-immunized DR4-transgenic mice, we determined that human ex vivo differentiated DR4(+) dendritic cells (DC) and macrophages (Mphi) can mediate MHC class II presentation of CII or HCgp39 epitopes. The form of the Ag (soluble, partially degraded, or particulate) delivered to the APC influenced its presentation by DC and Mphi. DC efficiently presented partially degraded, but not native CII alpha-chains, while Mphi presentation was most efficient after phagocytosis of bead-conjugated CII. Both DC and Mphi presented soluble HCgp39, and activated Mphi from some donors presented epitopes derived from endogenously synthesized HCgp39. When synovial fluid from rheumatoid arthritis patients was used as a source of Ag, DC presentation of HCgp39 and CII epitopes was efficient, indicating that synovial fluid contains soluble forms of CII and HCgp39 amenable to internalization, processing, and presentation. These data support the hypothesis that CII and HCgp39 are autoantigens and that their class II-mediated presentation by DC and Mphi to T cells in vivo has a critical role in the pathogenesis of human rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12444176     DOI: 10.4049/jimmunol.169.11.6625

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

1.  Pivotal advance: peritoneal cavity B-1 B cells have phagocytic and microbicidal capacities and present phagocytosed antigen to CD4+ T cells.

Authors:  David Parra; Aja M Rieger; Jun Li; Yong-An Zhang; Louise M Randall; Christopher A Hunter; Daniel R Barreda; J Oriol Sunyer
Journal:  J Leukoc Biol       Date:  2011-11-04       Impact factor: 4.962

2.  Synovial biology and T cells in rheumatoid arthritis.

Authors:  Chinh N Tran; Steven K Lundy; David A Fox
Journal:  Pathophysiology       Date:  2005-10

3.  The role of antigen-presenting cells and interleukin-12 in the priming of antigen-specific CD4+ T cells by immune stimulating complexes.

Authors:  Neil C Robson; Helen Beacock-Sharp; Anne M Donachie; Allan McI Mowat
Journal:  Immunology       Date:  2003-09       Impact factor: 7.397

Review 4.  B cells as effectors and regulators of sex-biased arthritis.

Authors:  David Luckey; Kay Medina; Veena Taneja
Journal:  Autoimmunity       Date:  2012-08       Impact factor: 2.815

Review 5.  Targeting of tolerogenic dendritic cells towards heat-shock proteins: a novel therapeutic strategy for autoimmune diseases?

Authors:  Manon A A Jansen; Rachel Spiering; Femke Broere; Jacob M van Laar; John D Isaacs; Willem van Eden; Catharien M U Hilkens
Journal:  Immunology       Date:  2017-09-18       Impact factor: 7.397

6.  Functional regulatory immune responses against human cartilage glycoprotein-39 in health vs. proinflammatory responses in rheumatoid arthritis.

Authors:  Jolanda H M van Bilsen; Henrike van Dongen; Leroy R Lard; Ellen I H van der Voort; Diënne G Elferink; Aleida M Bakker; André M M Miltenburg; Tom W J Huizinga; René R P de Vries; René E M Toes
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

Review 7.  Is the sugar always sweet in intestinal inflammation?

Authors:  Emiko Mizoguchi; Atsushi Mizoguchi
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

8.  High production of proinflammatory and Th1 cytokines by dendritic cells from patients with rheumatoid arthritis, and down regulation upon FcgammaR triggering.

Authors:  T R D J Radstake; P L E M van Lent; G J Pesman; A B Blom; F G J Sweep; J Rönnelid; G J Adema; P Barrera; W B van den Berg
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

9.  In vitro biological activity of anti-C II TA hammerhead ribozyme--a novel approach for autoimmune diseases.

Authors:  Fang Liu; Ping Zou; Rong Guo; Huazhong Lu; Huahua Fan
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

10.  Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.

Authors:  Steven K Lundy; David A Fox
Journal:  Arthritis Res Ther       Date:  2009-08-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.